Premium
Letter: dose optimising infliximab in acute severe ulcerative colitis
Author(s) -
Choy M. C.,
De Cruz P.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13980
Subject(s) - infliximab , medicine , ulcerative colitis , gastroenterology , colitis , tumor necrosis factor alpha , disease